Kazia Therapeutics (KZIA) Total Liabilities (2009 - 2025)

Kazia Therapeutics has reported Total Liabilities for 15 years, with the latest figure at $16.2 million in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities rose 13.93% year-over-year to $16.2 million; the trailing twelve-month figure through Dec 2025 stood at $16.2 million (up 13.93% YoY), and the FY2025 full-year result was $9.2 million, down 55.84% from the prior year.
• Total Liabilities for Q4 2025 stood at $16.2 million, up from $9.2 million in the prior quarter.
• The five-year high for Total Liabilities was $20.8 million in Q2 2024, with the low at $9.2 million in Q2 2025.
• Historically, Total Liabilities has averaged $13.6 million across 5 years, with a median of $13.3 million in 2022.
• Annual changes were most pronounced in 2021 — Total Liabilities jumped 166.02% — and 2025, when it sank 55.84%.
• Kazia Therapeutics' Total Liabilities stood at $14.0 million in 2021, then dropped by 23.56% to $10.7 million in 2022, then rose by 16.54% to $12.4 million in 2023, then rose by 14.14% to $14.2 million in 2024, then gained by 13.93% to $16.2 million in 2025.
• The last three Total Liabilities figures came in at $16.2 million (Q4 2025), $9.2 million (Q2 2025), and $14.2 million (Q4 2024), per Business Quant data.